Wednesday, 21 August 2013

Insecticide-treated bed nets critical to global elimination of filariasis




An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries.


The researchers, including Case Western Reserve University School of Medicine professor James Kazura, MD, found that insecticide-treated reduce transmission of lymphatic filariasis to undetectable levels – even in the absence of additional medication. Their study appears in the August 22 issue of The New England Journal of Medicine.


The World Health Organization reports that more than 120 million people suffer from lymphatic filariasis, commonly known as . About a third of that number are disfigured or disabled by the disease, a parasitic- spread by mosquitoes.


"Our study quantifies the effect of the most widely implemented vector control measure – insecticide-treated bed nets – and highlights the importance of integrating this type of intervention as a part of the global strategy to eliminate lymphatic filariasis," said Kazura, the paper's senior author and director of the medical school's Center for Global Health and Diseases. "With a little bit of effort and not much money, we don't have to live with this painful, disfiguring disease."


This study follows research that Kazura published in in 2002 The New England Journal of Medicine. In that work, he and his colleagues evaluated the safety and efficacy of administered annual antifilarial drugs over five years to residents of five villages in Papua New Guinea. The team demonstrated that the mass drug strategy nearly eliminated the parasite from humans but did not stop its transmission by mosquitoes.


The success of a strategy utilizing medication requires at least 80 percent of the population to receive treatment annually for at least five years. The initial results of mass treatment showed promising results, but transmission still took place in subsequent years, albeit at lower rates. Testing showed that parasite levels remained high in mosquitoes around the villages as much as decade later.


Ten years after villagers took their last medication round, they received free bed nets as part of Papua New Guinea's national malaria control effort. In the 36 months that followed, Kazura and team saw a dramatic decrease in the number of infected mosquito bites per person. In fact, rates fell annually from as many as 325 to zero. Kazura and his colleagues ultimately concluded that transmission has stopped completely; they could find no mosquitoes harboring parasites capable of transmitting the disease.


Insecticide-treated bed nets already are used widely in areas where lymphatic filariasis and malaria are present. They block female mosquitoes from securing blood, a process that is essential for them to lay eggs and produce offspring. The insecticide reduces the life-span of the insect by half, preventing it from living long enough for the parasite to become capable of transmission.


The researchers also discovered that the bed nets caused the insects to alter their biting behavior. Specifically, they did not seek to eat when the parasite reached its peak level in the human bloodstream – between midnight and 2:00 a.m. When the mosquitoes bite earlier in the day, they ingest fewer parasites, and thus, further compromise transmission of the infection to another human.


"We should not rely solely on mass drug administration to eliminate lymphatic filariasis. By combining the existing strategy with , we are more likely to reach elimination thresholds," said Lisa J. Reimer, PhD, first author on the paper and a lecturer at the Liverpool School of Tropical Medicine. "Our findings clearly demonstrate this low-cost solution could complement the successes of the current elimination program while having a high pay-off for both filariasis and malaria control."


Kazura and his colleagues in Papua New Guinea plan to study progress in eliminating the disease over the next several years. The group also will test new drug combinations for mass treatment in nearby populations and evaluate the effects of broader bed net distribution in the country.


Kazura and Reimer collaborated with researchers from Papua New Guinea Institute of Medical Research, Papua New Guinea Department of Health, Liverpool School of Tropical Medicine, University of Queensland, University of Notre Dame and Case Western Reserve University School of Medicine.



Medical Xpress on facebook

Related Stories


Study finds use of bed nets by 75 percent of population could eradicate malaria


Mar 07, 2013



Malaria, the leading cause of death among children in Africa, could be eliminated if three-fourths of the population used insecticide-treated bed nets, according to a new study from the National Institute for Mathematical ...



New test better detects elephantiasis worm infection


May 20, 2013



A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...



Disease-carrying mosquitos pack twice the punch


Jun 17, 2013



An international team of researchers from the University of Notre Dame's Eck Institute for Global Health and Imperial College London has recently published its work on a malaria-filaria co-transmission model, ...



Recently published research targets malaria mosquito control woes


May 07, 2013



(Medical Xpress)—Malaria is responsible for about 700,000 deaths annually in sub-Saharan Africa alone, and a team of Texas A&M University researchers is doing their best to help stem this perpetual tide of human suffering.



Bacillus thuringiensis Cry4B toxin kills Anopheles gambiae, a principal vector of malaria


Jun 05, 2013



Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have characterized a protein produced by the soil bacterium Bacillus thuringiensis subsp. israelensis (Bti), which is highly toxic against Anoph ...



Recommended for you


Two studies identify potential new drug for Crohn's disease and ulcerative colitis


15 seconds ago



Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. ...



Virus changes its stripes: Outbreak in Panama brought Latin America's first human cases of eastern equine encephalitis


16 seconds ago



In the summer of 2010, the eastern Panamanian province of Darien experienced a phenomenon that had never been seen before in Latin America: a human outbreak of eastern equine encephalitis.





US issues advisory for Cuba over cholera cases


1 hour ago



The United States has issued an advisory for travelers to Cuba after several foreign visitors were sickened by cholera in recent weeks.



Tuberculosis genomes portray secrets of pathogen's success


1 hour ago



By any measure, tuberculosis (TB) is a wildly successful pathogen. It infects as many as two billion people in every corner of the world, with a new infection of a human host estimated to occur every second.





MERS virus discovered in bat near site of outbreak in Saudi Arabia


2 hours ago



A 100% genetic match for Middle East Respiratory Syndrome (MERS) has been discovered in an insect-eating bat in close proximity to the first known case of the disease in Saudi Arabia. The discovery points ...



Scientists find another flu virus in Chinese chickens


2 hours ago



Scientists studying the H7N9 bird flu virus that has killed more than 40 people since March said Wednesday they had discovered another H7-type virus lurking in chickens in China.



User comments








An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries.


The researchers, including Case Western Reserve University School of Medicine professor James Kazura, MD, found that insecticide-treated reduce transmission of lymphatic filariasis to undetectable levels – even in the absence of additional medication. Their study appears in the August 22 issue of The New England Journal of Medicine.


The World Health Organization reports that more than 120 million people suffer from lymphatic filariasis, commonly known as . About a third of that number are disfigured or disabled by the disease, a parasitic- spread by mosquitoes.


"Our study quantifies the effect of the most widely implemented vector control measure – insecticide-treated bed nets – and highlights the importance of integrating this type of intervention as a part of the global strategy to eliminate lymphatic filariasis," said Kazura, the paper's senior author and director of the medical school's Center for Global Health and Diseases. "With a little bit of effort and not much money, we don't have to live with this painful, disfiguring disease."


This study follows research that Kazura published in in 2002 The New England Journal of Medicine. In that work, he and his colleagues evaluated the safety and efficacy of administered annual antifilarial drugs over five years to residents of five villages in Papua New Guinea. The team demonstrated that the mass drug strategy nearly eliminated the parasite from humans but did not stop its transmission by mosquitoes.


The success of a strategy utilizing medication requires at least 80 percent of the population to receive treatment annually for at least five years. The initial results of mass treatment showed promising results, but transmission still took place in subsequent years, albeit at lower rates. Testing showed that parasite levels remained high in mosquitoes around the villages as much as decade later.


Ten years after villagers took their last medication round, they received free bed nets as part of Papua New Guinea's national malaria control effort. In the 36 months that followed, Kazura and team saw a dramatic decrease in the number of infected mosquito bites per person. In fact, rates fell annually from as many as 325 to zero. Kazura and his colleagues ultimately concluded that transmission has stopped completely; they could find no mosquitoes harboring parasites capable of transmitting the disease.


Insecticide-treated bed nets already are used widely in areas where lymphatic filariasis and malaria are present. They block female mosquitoes from securing blood, a process that is essential for them to lay eggs and produce offspring. The insecticide reduces the life-span of the insect by half, preventing it from living long enough for the parasite to become capable of transmission.


The researchers also discovered that the bed nets caused the insects to alter their biting behavior. Specifically, they did not seek to eat when the parasite reached its peak level in the human bloodstream – between midnight and 2:00 a.m. When the mosquitoes bite earlier in the day, they ingest fewer parasites, and thus, further compromise transmission of the infection to another human.


"We should not rely solely on mass drug administration to eliminate lymphatic filariasis. By combining the existing strategy with , we are more likely to reach elimination thresholds," said Lisa J. Reimer, PhD, first author on the paper and a lecturer at the Liverpool School of Tropical Medicine. "Our findings clearly demonstrate this low-cost solution could complement the successes of the current elimination program while having a high pay-off for both filariasis and malaria control."


Kazura and his colleagues in Papua New Guinea plan to study progress in eliminating the disease over the next several years. The group also will test new drug combinations for mass treatment in nearby populations and evaluate the effects of broader bed net distribution in the country.


Kazura and Reimer collaborated with researchers from Papua New Guinea Institute of Medical Research, Papua New Guinea Department of Health, Liverpool School of Tropical Medicine, University of Queensland, University of Notre Dame and Case Western Reserve University School of Medicine.



Medical Xpress on facebook

Related Stories


Study finds use of bed nets by 75 percent of population could eradicate malaria


Mar 07, 2013



Malaria, the leading cause of death among children in Africa, could be eliminated if three-fourths of the population used insecticide-treated bed nets, according to a new study from the National Institute for Mathematical ...



New test better detects elephantiasis worm infection


May 20, 2013



A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...



Disease-carrying mosquitos pack twice the punch


Jun 17, 2013



An international team of researchers from the University of Notre Dame's Eck Institute for Global Health and Imperial College London has recently published its work on a malaria-filaria co-transmission model, ...



Recently published research targets malaria mosquito control woes


May 07, 2013



(Medical Xpress)—Malaria is responsible for about 700,000 deaths annually in sub-Saharan Africa alone, and a team of Texas A&M University researchers is doing their best to help stem this perpetual tide of human suffering.



Bacillus thuringiensis Cry4B toxin kills Anopheles gambiae, a principal vector of malaria


Jun 05, 2013



Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have characterized a protein produced by the soil bacterium Bacillus thuringiensis subsp. israelensis (Bti), which is highly toxic against Anoph ...



Recommended for you


Two studies identify potential new drug for Crohn's disease and ulcerative colitis


15 seconds ago



Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. ...



Virus changes its stripes: Outbreak in Panama brought Latin America's first human cases of eastern equine encephalitis


16 seconds ago



In the summer of 2010, the eastern Panamanian province of Darien experienced a phenomenon that had never been seen before in Latin America: a human outbreak of eastern equine encephalitis.





US issues advisory for Cuba over cholera cases


1 hour ago



The United States has issued an advisory for travelers to Cuba after several foreign visitors were sickened by cholera in recent weeks.



Tuberculosis genomes portray secrets of pathogen's success


1 hour ago



By any measure, tuberculosis (TB) is a wildly successful pathogen. It infects as many as two billion people in every corner of the world, with a new infection of a human host estimated to occur every second.





MERS virus discovered in bat near site of outbreak in Saudi Arabia


2 hours ago



A 100% genetic match for Middle East Respiratory Syndrome (MERS) has been discovered in an insect-eating bat in close proximity to the first known case of the disease in Saudi Arabia. The discovery points ...



Scientists find another flu virus in Chinese chickens


2 hours ago



Scientists studying the H7N9 bird flu virus that has killed more than 40 people since March said Wednesday they had discovered another H7-type virus lurking in chickens in China.



User comments








Categories:

0 comments:

Post a Comment